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Fig. 1. As one of the first steps in his studies of using 
blood serum in calfhood disease control, Dr. Staples adds 
chernical sterilant to a sample of serum from slaughter 
blood.
Blood and blood components have been used 
for many years to reduce death losses caused by 
calfhood diseases (1, 2, 9, 10, 11, 12).
The cliche “ too little and too late” could often 
be applied to the use of blood or serum in calf 
disease control. Economics is the chief reason these 
products are not used more extensively. It is costly 
in veterinary time to collect and administer sterile 
whole blood, and blood has a short storage life. It 
is likewise costly to use commercial antiserums in 
the amounts suggested as necessary to be most 
effective (1, 4, 12). Such amounts (700 ml or more) 
would often equal or exceed half the value of the 
calf being treated.
Substantial reduction in death losses among 
young calves with diarrhea has been accomplished 
through the use of ordinary plasma or serum from 
adult cattle (10, 12). Such products can also substi­
tute for colostrum (10). It has been reported (4)
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that adult bovine serum is as high as commercial 
anti-serums in gamma globulin, a major antibody 
fraction found in blood serum. These and other re­
ports suggest an answer to the cost problem. It 
might be solved by finding a practical and econom­
ical method of recovering serum and plasma from 
the packing industry where blood is a low-priced or 
a waste product. Some calves, even after ingesting 
colostrum, appear to be very short of circulating 
antibodies and would probably get increased re­
sistance from a generous injection of blood, plasma 
or serum from adult cattle.
With these and other considerations in mind, 
investigation of problems related to collecting, ster­
ilizing, storage and using slaughter blood and ser­
um have been initiated. The time-consuming pro­
cedures necessary to collect blood aseptically from 
an automated modern kill line were obviously im­
practical. An alternate approach was to investigate 
agents or methods that could render blood or serum 
sterile without destroying immune properties. Ide­
ally, an agent or method should be viricidal, bacter-
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Fig 2. Dr. Staples gets a measure of the relative toxicity to animals of 
the*various treatments for sterilizing the serum from intraperitoneal in­
jection of the treated serum into laboratory mice.
icidal and mycostatic (fungus-inhibiting) at levels 
low enough to be relatively nontoxic to calves.
Antibiotics, heat and phenol were initially 
tried as serum sterilants. Each has disadvantages. 
Antibiotics are not viricidal or mycostatic. Heat at 
temperatures required to destroy various micro­
organisms will cause coagulation and destroys some 
disease-inhibiting powers in the serum (3, 8). Phe­
nol employed at low levels in aseptically collected 
commercial.serums produced severe reactions in 
mice, baby pigs and rabbits when injected in large 
doses. It is also doubtful that such levels would 
destroy the bacterial loads in serum collected from 
an automated kill line.
Literature search (5, 6, 7) revealed an interest­
ing and promising compound, beta-propiolactone 
(BPL). It has been used successfully as a viricide 
and bactericide in human blood fractions as well 
as in sterilizing human tissues for surgical trans­
plant. It’-is a colorless liquid, stable when stored 
between -15° and -30° C. When mixed with aque­
ous solutions it is very unstable and rapidly de­
grades into relatively nontoxic forms, chiefly hy- 
dracrylic acid. During the degradation process it 
will completely inactivate a variety of bacteria and 
virus. In the pure form it must be handled with the 
same precautions appropriate in handling strong 
acids and alkalies.
Procedures
I. Blood Collection and Serum Separation
Blood was collected in sterile gallon jars by 
the sticker on the kill line of a local packing plant.* 
One gallon was taken from each animal without 
slowing the automated process of the line. After 
clotting and standing overnight at approximately 
5° C., the serum was poured off and residual red 
cells removed by centrifugation employing sterile 
techniques.
II. Bacterial Cultures
Following centrifugation, s t a n d a r d  colony
counts were made on serum from each jar to estab­
lish bacterial load. Bacterial culture in differential 
media was performed on 50 lots to establish the 
genera of bacteria present. No attempt was made to 
establish the ratio of the different genera in any of 
the lots containing mixed cultures. Those samples 
containing three million or more bacteria per ml 
were designated “high count” and those below this 
figure designated “ low count” . Serums so designat­
ed were pooled in the appropriate category and a
* Sincere appreciation is expressed to the management and
personnel at the Siouxland Dressed Beef Plant (S. E.
Needham), West Fargo, North Dakota, for their excellent
assistance in collecting blood for experimental use.
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final bacterial count made on each of the pooled 
18ts.
Cultures were also made on a number of 
matching clots, especially where serums were neg­
ative to colony counts or to culture of a loop of 
serum on differential media. The clots were frag­
mented into sterile physiological saline by means 
of an improvised “ clot breaking tube” and culture 
made from the solution after vigorous shaking. 
Clot cultures sometimes yielded one or more gen­
era of bacteria in addition to those isolated from 
the matching serum. It was also found that it was 
necessary to incubate a small amount of an appar­
ently negative serum sample overnight and recul­
ture to assure that sterility was absolute. Culturing 
of a loopful of serum or making a plate colony 
count would not always disclose growth where the 
sample was of extremely low bacterial count.
III. Sterilization and Storage
Storage procedures utilized various types of 
containers including 10-liter polyethylene bags (or­
iginally designed for milk-dispensing containers), 
500 ml glass serum bottles with rubber stoppers, 
and a variety of screw-top culture tubes and glass 
bottles. Glass containers were sterilized by auto­
claving. Polyethylene containers depended on the 
chemical sterilant to achieve sterility during the 
serum-sterilizing process.
One phase of the study compared the keeping 
qualities of serum treated with different steriliza­
tion methods, then stored under three different 
temperatures (approximately 5° C, 22° C and incu­
bator temperature of exactly 37° C).
Four methods were used to sterilize serum.
1. Phenol 1:500 (volume to volume).
2. Heat 60° C for 30 minutes.
3. Penicillin — dihydrostreptomycin sul­
fate at 0.5 percent (volume to volume)
with potency of 200,000 units of peni­
cillin G and 250 mg dihydrostreptomy­
cin sulfate per ml of additive.
4. Beta-propiolactone 3 ml per liter of ser­
um. Two products, 97 percent and 99
percent pure were premixed with 4
parts water immediately prior to adding
to the serum. In pilot trials, 1 to 1.5 ml
BPL per liter was bactericidal for most
serum samples.
Sterility checks for bacteria were performed 
24 hours following the sterilizing procedure. Some 
lots were rechecked, particularly the larger ones 
where serum had been withdrawn for animal in­
jections. No procedures related to virus isolations 
were performed.
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IV. Animal Injections
Serum which was stored in bulk lots and 
maintained sterility-and good physical appearance 
was utilized in calf disease studies after the safety 
was tested by injecting laboratory animals.
Results
I. The serum yield varied from 20 percent to 
33 percent of the blood volume. Yield could be in­
creased through centrifugation of the whole blood.
II. The bacterial loads in more than 200 in­
dividual gallon samples ranged from zero (0) to 
19,205,000 bacteria per ml of serum. It is postulat­
ed that the negative serums either possessed in­
hibitory qualities (3, 8) or contained a slight anti­
biotic residue, since aseptic collection techniques 
were impractical under the automated conditions 
of the kill line. Another possibility is that such a 
sample contained relatively few bacteria and these 
were trapped in the clot and removed. Checking the 
matching clot from some negative serum samples 
yielded bacterial growth from the clot.
Table 1 lists the different genera (more than 
one species in some genera) of bacteria distinguish­
ed and shows the frequency of occurrence in 50 
samples representing serum from individual ani­
mals before sterilization. Many samples contained 
two or more genera.
Table 1. Genera of bacteria in 50 blood samples.
Genera Frequency of Occurrence
Aerobacter 15
Bacillus 3
Candida 1
Clostridium 2
Corynebacterium 2
Diplococci 12
Escherichia 41
Gaffyka 1
Micrococci 19
Pasteurella 1
Proteus 4
Pseudomonas 21
Serratia 13
Staphylococci 58
Streptococci 38
III. Bacterial sterility was achieved in certain 
lots of serum by all four methods. Beta propiolac- 
tone appeared superior when both sterility and 
physical appearances were considered during long­
term storage at environmental temperatures of 5° 
C and 22° C. None of the methods gave consistently 
good results regarding physical appearance on
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samples stored at 37° C, even though a few samples 
preserved with BPL appeared to be suitable for 
intravenous (I.V.) use for up to two years stored at 
37° C. Some samples preserved with BPL appear 
suitable for I.V. use after four years storage at 5° 
C. Those samples of heat-sterilized serum which 
remained sterile compare favorably in physical ap­
pearance with the BPL-preserved samples after 
long-term storage. Acceptable physical appearance 
was based on normal viscosity and absence of par­
ticles and precipitates.
Two chief problems were seen in the storage 
serum besides the fact that few of them maintained 
good physical appearance after several months 
storage at 37° C. One problem was slow-developing 
mycotic forms. The other was precipitation of par­
ticles that would render the serum unsuitable for 
I.V. injections. Possible solutions to these problems 
might be to include an additional mycostatic agent 
prior to sterilization. Adjusting the pH toward neu­
tral might assist in reducing precipitates since 
treatment with BPL lowered the pH approximately 
0.5 point for every ml of the compound added per 
liter of serum. Filtering the serum after several 
months storage at 5° C produced good physical ap­
pearance for extended periods.
IV. Routine sterility checking after steriliza­
tion procedures had been applied was used to estab­
lish a safety index prior to injecting serum in calf 
disease studies. Mice were the usual animals used 
since they proved to be relatively unaffected by 
heterologous serum injections as compared to rab­
bits. Injecting five ml of sterilized serum via intra- 
peritoneal route into 40 gram (approximately) mice 
for three consecutive days produced less than 25 
percent mortality except in the case of serums 
sterilized with phenol. Four such consecutive in­
jections of commercially prepared serums (which 
are apparently prepared with phenol) produced 89 
per cent mortality (in 55 mice). The same dosage of 
serum sterilized with 3 ml per liter of BPL pro­
duced 26.3 per cent mortality in 51 mice.
In calves, serums having high bacterial loads 
prior to sterilization appeared to be more difficult 
to administer intravenously or intraperitoneally 
without causing undesirable clinical symptoms such 
as rapid and labored breathing and signs of dis­
comfort and depression. Other factors also appear 
to be involved, as certain low bacterial count ser­
ums from any of the four methods of sterilization 
also showed undesirable symptoms especially when 
administered intravenously. Such undesirable re­
actions may be due to pH readings of 5.0 to 6.0 or 
possibly to different protein fraction patterns.
These possibilities require further investiga­
tion. Little difference could be seen in clinical signs 
when sterilized serums from “ high count” bac­
terial lots and “ low count” bacterial lots were 
given orally as a colostrum substitute. Up to 1,000 
ml of BPL-sterilized serum were administered via 
the intraperitoneal route within a 15-minute period 
without the animals showing more than a transient 
discomfort. Observable signs and symptoms when 
injected into calves or piglets indicate serums steri­
lized with beta-propiolactone are at least as safe as 
commercial preparations. A major problem in 
using the most promising agent tried (beta-propio­
lactone) is to clear the compound with the Food and 
Drug Administration for use in food-producing 
animals.
Summary
Initial investigations of the practicality of ob­
taining bovine serum from packing house opera­
tions have shown promising results. Of the four 
sterilizing procedures used, the most promising is 
the use of the chemical agent beta-propiolactone as 
a sterilant. It appears to have good bactericidal and 
viricidal properties (the latter indicated from liter­
ature review) (5, 6, 7) as well as fair mycostatic pro­
perties. It also showed low toxicity at effective ster­
ilization levels when serum so sterilized was inject­
ed into calves, piglets or mice.
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